Clinical Trials Logo

Acute Watery Diarrhea clinical trials

View clinical trials related to Acute Watery Diarrhea.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05216822 Completed - Clinical trials for Acute Watery Diarrhea

Anti-Secretory Drug in Treatment of Acute Watery Diarrhea

Start date: June 1, 2018
Phase: Phase 1
Study type: Interventional

In conclusion, racecadotril is an anti-secretory drug that exerts its antidiarrheal effect by inhibiting intestinal enkephalinase. It is effective in reducing the volume and frequency of stool output. racecadotril is well tolerated and safe by providing symptomatic relief and reducing the severity of diarrhea as an adjuvant therapy during the acute attack of gastroenteritis. It is recommended that the new generations of already discovered drugs for control of secretory diarrhea should be studied to discover the ones with fewer side effects to other systems in the body.